| Thursday May 2 | |||
|---|---|---|---|
| 9:00 am – 5:00 pm | SPARTAN Trainee Symposium | ||
| 3:00 – 5:00 pm | CLASSIC Investigator Meeting | ||
| 5:30 – 7:00 pm | Welcome Reception and Poster Viewing | ||
| Friday May 3 | |||
| 8:10 – 11:10 am | Scientific Session 1 “New Developments in Imaging of SpA” Moderator: Walter Maksymowych, MD University of Alberta, Edmonton |
||
| 8:10 – 8:50 am | Robert Lambert, MB BCh, FRCR, FRCPC University of Alberta |
“Low radiation CT and advances in MRI for detection of structural lesions in axSpA” | |
| 8:50 – 9:30 am | Xenofon Baraliakos, MD Ruhr-University Bochum, Germany |
“Assessment of Progression in AxSpA: Is there still a role for plain radiography?” | |
| 9:50 – 10:30 am | Maxime Dougados, MD René Descartes University and Hôpital Cochin, Paris |
“What does imaging tell us about prognosis in SpA?” | |
| 10:30 – 11:10 am | Sovira Tan, PhD NIH/NIAMS, Bethesda |
“Imaging insights into SpA pathogenesis” | |
| 11:15 – 12:15 pm | Breakout Sessions | ||
| 1:30 – 3:30 pm | Scientific Session 2 “Gut microbiome and inflammation in SpA pathogenesis” Moderator: Robert Colbert, MD, PhD NIH/NIAMS, Bethesda |
||
| 1:30 – 2:10 pm | Mark Asquith, BSc, MSc, PhD Oregon Health & Science University, Portland |
“Gut microbiome and SpA pathogenesis” | |
| 2:10 – 2:50 pm | Jose Scher, MD New York University School of Medicine, New York |
“Dysbiosis in human SpA” | |
| 2:50 – 3:30 pm | Charles Bernstein, MD University of Manitoba, Winnipeg |
“Management of co-morbid IBD and SpA: A gastroenterologist’s perspective” | |
| 4:00-5:00 pm | Oral Abstract Presentations Moderator: Nigil Haroon, MD, PhD University Health Network, Toronto |
||
| 5:00-6:00 pm | Seed Grant Awardee Presentations | ||
| Jonathan Chan, MD, MSc University of British Columbia, Vancouver |
“Validation of administrative billing codes for the diagnosis of axial SpA” | ||
| Maureen Dubreuil, MD, MSc Boston University School of Medicine |
“Development of Minimal Disease Activity criteria in Axial SpA” | ||
| Kristi Kuhn, MD, PhD University of Colorado School of Medicine, Denver |
“Understanding the pathophysiology of spondyloarthritis by characterizing trafficking lymphocytes in the gut-joint axis” | ||
| Runsheng Wang, MD MHS Columbia University Medical Center, New York |
“N-of-1 trials in axial SpA “ | ||
| 6:30 – 9:00 pm | Annual Reception at the Wisconsin Institute of Discovery University of Wisconsin |
||
| Saturday May 4 | |||
| 8:00 – 8:30 am | SPARTAN Business Meeting | ||
| 8:30-9:30 am | Maxime Dougados, MD | Keynote Address “Lessons from the DESIR cohort” |
|
| 9:45am-12:40 pm | Scientific Session 3 “Moving Ax SpA Clinical Research Forward: thinking outside the box” Moderator: Judith Smith, PhD, MD |
||
| 9:45-10:25 am | Theresa Walunas, PhD Northwestern Medicine, Chicago |
“Harnessing the potential of EMR for rheumatology research” | |
| 10:25-11:05 am | Alexis Ogdie-Beatty, MD, MSCE University of Pennsylvania, Philadelphia |
“Personal Technology in Clinical Trials” | |
| 11:20-12:00 pm | Maureen Dubreuil, MD, MSc Boston University School of Medicine, Boston |
“Beyond the drug trial: cost-effectiveness research?” | |
| 12:00-12:40 pm | Sherry Rohekar, MD, FRCPC Western University, London, Ontario |
“Work disability/presenteeism in SpA” | |
